000279443 001__ 279443
000279443 005__ 20250720001552.0
000279443 0247_ $$2doi$$a10.1093/braincomms/fcaf228
000279443 0247_ $$2pmid$$apmid:40574970
000279443 0247_ $$2pmc$$apmc:PMC12199781
000279443 0247_ $$2altmetric$$aaltmetric:179019639
000279443 037__ $$aDZNE-2025-00774
000279443 041__ $$aEnglish
000279443 082__ $$a610
000279443 1001_ $$00000-0002-3291-7222$$ade Almeida Marcelino, Ana Luísa$$b0
000279443 245__ $$aLesion distribution and network mapping in dyskinetic cerebral palsy.
000279443 260__ $$a[Oxford]$$bOxford University Press$$c2025
000279443 3367_ $$2DRIVER$$aarticle
000279443 3367_ $$2DataCite$$aOutput Types/Journal article
000279443 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1752564405_3118
000279443 3367_ $$2BibTeX$$aARTICLE
000279443 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000279443 3367_ $$00$$2EndNote$$aJournal Article
000279443 520__ $$aDyskinetic cerebral palsy encompasses a group of predominantly perinatally acquired complex motor disorders that present with dystonia and/or choreoathetosis and are frequently associated with brain lesions in neuroimaging. Recently, lesion network mapping provided a tool to redefine neurological disorders as circuitopathies. Elucidating the common networks impacted by lesions in this condition could pave the way to identify new targets for neuromodulatory therapeutic approaches. In this study, we aim to assess lesion distribution in dyskinetic cerebral palsy and identify a related functional network derived from lesions. Here, we review the literature of MRI findings in dyskinetic cerebral palsy and perform literature-based lesion network mapping. Articles reporting conventional MRI findings clearly attributable to affected patients were included for review. Imaging findings and their anatomical distribution were extracted and quantified according to an established MRI classification system for cerebral palsy. Reviewed articles were searched for figures depicting lesions and these were traced onto a paediatric template. Whole-brain functional connectivity from lesions causing dyskinetic cerebral palsy was calculated using a paediatric resting-state functional MRI connectome. Individual maps were thresholded and later overlapped to derive a common network map associated with dyskinetic cerebral palsy. Results were contrasted with two control datasets for spatial specificity. Review of 48 selected articles revealed that grey matter injury predominated (51%), followed by white matter injury (28%). In 16% of cases MRI was normal. Subcortical lesions affected the thalamus, pallidum and putamen in >40% of reported patients, respectively. Figures available from 23 literature cases were used to calculate the lesion netwok map of dyskinetic cerebral palsy. The lesion-derived map revealed functional connectivity to a wide network including the brainstem, cerebellum, basal ganglia, cingulate and sensorimotor cortices. The strongest connectivity was found for the motor thalamus. This study confirms subcortical grey matter lesions as the most common MRI finding in dyskinetic cerebral palsy. The neural network identified with lesion network mapping includes areas previously implicated in hyperkinetic disorders and highlights the motor thalamus as a common network node. These results should be validated and their therapeutic implications explored in prospective trials.
000279443 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000279443 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000279443 650_7 $$2Other$$adyskinetic cerebral palsy
000279443 650_7 $$2Other$$alesion network mapping
000279443 650_7 $$2Other$$alesion pattern
000279443 650_7 $$2Other$$aneuroimaging
000279443 7001_ $$00000-0003-0067-6177$$aAl-Fatly, Bassam$$b1
000279443 7001_ $$aTuncer, Mehmet S$$b2
000279443 7001_ $$aKrägeloh-Mann, Ingeborg$$b3
000279443 7001_ $$00000-0002-7991-4432$$aKoy, Anne$$b4
000279443 7001_ $$0P:(DE-2719)2811089$$aKühn, Andrea$$b5$$eLast author$$udzne
000279443 773__ $$0PERI:(DE-600)3020013-1$$a10.1093/braincomms/fcaf228$$gVol. 7, no. 3, p. fcaf228$$n3$$pfcaf228$$tBrain communications$$v7$$x2632-1297$$y2025
000279443 8564_ $$uhttps://pub.dzne.de/record/279443/files/DZNE-2025-00774%20SUP.pdf
000279443 8564_ $$uhttps://pub.dzne.de/record/279443/files/DZNE-2025-00774.pdf$$yOpenAccess
000279443 8564_ $$uhttps://pub.dzne.de/record/279443/files/DZNE-2025-00774%20SUP.pdf?subformat=pdfa$$xpdfa
000279443 8564_ $$uhttps://pub.dzne.de/record/279443/files/DZNE-2025-00774.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000279443 909CO $$ooai:pub.dzne.de:279443$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000279443 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811089$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b5$$kDZNE
000279443 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000279443 9141_ $$y2025
000279443 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-20
000279443 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000279443 915__ $$0StatID:(DE-HGF)0112$$2StatID$$aWoS$$bEmerging Sources Citation Index$$d2024-12-20
000279443 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bBRAIN COMMUN : 2022$$d2024-12-20
000279443 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2024-04-03T10:36:45Z
000279443 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2024-04-03T10:36:45Z
000279443 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2024-12-20
000279443 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-20
000279443 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2024-12-20
000279443 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000279443 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2024-04-03T10:36:45Z
000279443 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2024-12-20
000279443 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-20
000279443 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-20
000279443 9201_ $$0I:(DE-2719)5000008$$kAG Kühn$$lMovement Disorders (Parkinson's disease, Dystonia)$$x0
000279443 980__ $$ajournal
000279443 980__ $$aVDB
000279443 980__ $$aUNRESTRICTED
000279443 980__ $$aI:(DE-2719)5000008
000279443 9801_ $$aFullTexts